QA: Zevra Therapeutics INC in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001434647_2026_Zevra_Therapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001434647, Zevra Therapeutics INC

  xvar xval
0 AssetsCurrent 223,007,000
1 IntangibleAssetsNetIncludingGoodwill 11,122,000
2 PropertyPlantAndEquipmentNet 489,000
3 remainder_Assets 50,113,000
4 LiabilitiesCurrent 39,277,000
5 LiabilitiesNoncurrent 64,500,000
6 remainder_Liabilities 26,297,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 149,960,135
9 ResearchAndDevelopmentExpense 14,438,477
10 remainder_Expenses 349,597,392
11 remainder_Revenues 31,555,447
12 remainder_NetIncome 21,662,763
13 remainder_ComprehensiveNetIncome 674,000
  yvar yval
0 Assets 284,731,000
1 Liabilities 130,074,000
2 Expenses 513,996,004
3 Revenues 31,555,447
4 StockholdersEquity 154,657,000
5 NetIncome -460,777,794
6 ComprehensiveNetIncome -460,440,794
7 BaseVar 491,346,607
8 EconomicCapitalRatiobeforeLimitedLiability -0.594
9 EconomicCapitalRatio 1.37

Edgar->Model Mapping

Feature Distribution

Change over Time